Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5529-5538

  Sharma, Sharad K ^a   Chintala, Navin K ^a   Vadrevu, Surya Kumari ^a   Patel, Jalpa ^a   Karbowniczek, Magdalena ^a   Markiewski, Maciej M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BREAST CANCER; CD4+ T LYMPHOCYTE; CELL COUNT; CELL MATURATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG METASTASIS; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SUPPRESSOR CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY; TUMOR PROMOTION; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CYTOLOGY; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LUNG TUMOR; PATHOLOGY; SECONDARY; TUMOR MICROENVIRONMENT;

ANIMALS; CELL LINE; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ANAPHYLATOXIN C5A; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 84929646029     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403215     Document Type: Article

References (44)

1. Ostrand-Rosenberg, S., P. Sinha, D. W. Beury, and V. K. Clements. 2012. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin. Cancer Biol. 22: 275-281.
2. Qian, B. Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L. R. Campion, E. A. Kaiser, L. A. Snyder, and J. W. Pollard. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225.
3. Franklin, R. A., W. Liao, A. Sarkar, M. V. Kim, M. R. Bivona, K. Liu, E. G. Pamer, and M. O. Li. 2014. The cellular and molecular origin of tumorassociated macrophages. Science 344: 921-925.
4. Qian, B. Z., and J. W. Pollard. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
5. Davies, L. C., S. J. Jenkins, J. E. Allen, and P. R. Taylor. 2013. Tissue-resident macrophages. Nat. Immunol. 14: 986-995.
6. Chaffer, C. L., and R. A. Weinberg. 2011. A perspective on cancer cell metastasis. Science 331: 1559-1564.
7. Schulz, C., E. Gomez Perdiguero, L. Chorro, H. Szabo-Rogers, N. Cagnard, K. Kierdorf, M. Prinz, B. Wu, S. E. Jacobsen, J. W. Pollard, et al. 2012. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336: 86-90.
8. Kaplan, R. N., S. Rafii, and D. Lyden. 2006. Preparing the "soil": the premetastatic niche. Cancer Res. 66: 11089-11093.
9. Sceneay, J., M. J. Smyth, and A. Möller. 2013. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 32: 449-464.
10. Holt, P. G., D. H. Strickland,M. E. Wikström, and F. L. Jahnsen. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8: 142-152.
11. Markiewski, M. M., and J. D. Lambris. 2007. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171: 715-727.
12. Vadrevu, S. K., N. K. Chintala, S. K. Sharma, P. Sharma, C. Cleveland, L. Riediger, S. Manne, D. P. Fairlie, W. Gorczyca, O. Almanza, et al. 2014. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. Cancer Res. 74: 3454-3465.
13. Pulaski, B. A., and S. Ostrand-Rosenberg. 2001. Mouse 4T1 breast tumor model. Curr. Protoc. Immunol. Chapter 20: Unit 20 22.
14. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
15. Arimilli, S., S. K. Sharma, R. Yammani, S. D. Reid, G. D. Parks, and M. A. Alexander-Miller. 2010. Pivotal advance: nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1. J. Leukoc. Biol. 87: 977-988.
16. Zaynagetdinov, R., T. P. Sherrill, P. L. Kendall, B. H. Segal, K. P. Weller, R. M. Tighe, and T. S. Blackwell. 2013. Identification of myeloid cell subsets in murine lungs using flow cytometry. Am. J. Respir. Cell Mol. Biol. 49: 180-189.
17. DuPré, S. A., D. Redelman, and K. W. Hunter, Jr. 2007. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci. Int. J. Exp. Pathol. 88: 351-360.
18. Shiner, E. K., B. C. Holbrook, and M. A. Alexander-Miller. 2014. CD4+ T cell subset differentiation and avidity setpoint are dictated by the interplay of cytokine and antigen mediated signals. PLoS ONE 9: e100175. Available at: http:// journals.plos.org/plosone/article?id510.1371/journal.pone.0100175.
19. Yan, H. H., M. Pickup, Y. Pang, A. E. Gorska, Z. Li, A. Chytil, Y. Geng, J. W. Gray, H. L. Moses, and L. Yang. 2010. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 70: 6139-6149.
20. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
21. Knutson, K. L., and M. L. Disis. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol. Immunother. 54: 721-728.
22. Reilly, R. T., M. B. Gottlieb, A. M. Ercolini, J. P. Machiels, C. E. Kane, F. I. Okoye, W. J. Muller, K. H. Dixon, and E. M. Jaffee. 2000. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res. 60: 3569-3576.
23. Markiewski, M. M., R. A. DeAngelis, F. Benencia, S. K. Ricklin-Lichtsteiner, A. Koutoulaki, C. Gerard, G. Coukos, and J. D. Lambris. 2008. Modulation of the antitumor immune response by complement. Nat. Immunol. 9: 1225-1235.
24. Strey, C. W., M. Markiewski, D. Mastellos, R. Tudoran, L. A. Spruce, L. E. Greenbaum, and J. D. Lambris. 2003. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198: 913-923.
25. Levy, N. L., R. Synderman, R. L. Ladda, and R. Lieberman. 1973. Cytogenetic engineering in vivo: restoration of biologic complement activity to C5-deficient mice by intravenous inoculation of hybrid cells. Proc. Natl. Acad. Sci. USA 70: 3125-3129.
26. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
27. Quezada, S. A., T. R. Simpson, K. S. Peggs, T. Merghoub, J. Vider, X. Fan, R. Blasberg, H. Yagita, P. Muranski, P. A. Antony, et al. 2010. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 207: 637-650.
28. Pulaski, B. A., and S. Ostrand-Rosenberg. 1998. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 58: 1486-1493.
29. Senaratne, S. G., G. Pirianov, J. L. Mansi, T. R. Arnett, and K. W. Colston. 2000. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br. J. Cancer 82: 1459-1468.
30. Schreiber, R. D., L. J. Old, and M. J. Smyth. 2011. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331: 1565-1570.
31. MacLean, J. A., W. Xia, C. E. Pinto, L. Zhao, H. W. Liu, and R. L. Kradin. 1996. Sequestration of inhaled particulate antigens by lung phagocytes. A mechanism for the effective inhibition of pulmonary cell-mediated immunity. Am. J. Pathol. 148: 657-666.
32. Thepen, T., N. Van Rooijen, and G. Kraal. 1989. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170: 499-509.
33. Young, M. R., R. A. Endicott, G. P. Duffie, and H. T. Wepsic. 1987. Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors. J. Leukoc. Biol. 42: 682-688.
34. Kan-Mitchell, J., J. C. Hengst, R. A. Kempf, R. K. Rothbart, S. M. Simons, A. S. Brooker, V. L. Kortes, and M. S. Mitchell. 1985. Cytotoxic activity of human pulmonary alveolar macrophages. Cancer Res. 45: 453-458.
35. Jackson, R. A., P. H. Lill, and J. D. Gangemi. 1986. Role of pulmonary macrophages in resistance to experimental metastasis. J. Leukoc. Biol. 40: 575-587.
36. Kaplan, R. N., R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, C. Costa, D. D. MacDonald, D. K. Jin, K. Shido, S. A. Kerns, et al. 2005. VEGFR1- positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
37. Peinado, H., M. Alecković, S. Lavotshkin, I. Matei, B. Costa-Silva, G. Moreno-Bueno, M. Hergueta-Redondo, C. Williams, G. García-Santos, C. Ghajar, et al. 2012. Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET. Nat. Med. 18: 883-891.
38. Sinha, P., V. K. Clements, S. K. Bunt, S. M. Albelda, and S. Ostrand-Rosenberg. 2007. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179: 977-983
39. Markiewski, M. M., D. Mastellos, R. Tudoran, R. A. DeAngelis, C. W. Strey, S. Franchini, R. A. Wetsel, A. Erdei, and J. D. Lambris. 2004. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J. Immunol. 173: 747-754.
40. Kennedy, R., and E. Celis. 2008. Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol. Rev. 222: 129-144.
41. Armstrong, T. D., V. K. Clements, B. K. Martin, J. P. Ting, and S. Ostrand-Rosenberg. 1997. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc. Natl. Acad. Sci. USA 94: 6886-6891.
42. Jakubzick, C., F. Tacke, J. Llodra, N. van Rooijen, and G. J. Randolph. 2006. Modulation of dendritic cell trafficking to and from the airways. J. Immunol. 176: 3578-3584.
43. Munger, J. S., X. Huang, H. Kawakatsu, M. J. Griffiths, S. L. Dalton, J. Wu, J. F. Pittet, N. Kaminski, C. Garat, M. A. Matthay, et al. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
44. Winter, C., K. Taut, M. Srivastava, F. Länger, M. Mack, D. E. Briles, J. C. Paton, R. Maus, T. Welte, M. D. Gunn, and U. A. Maus. 2007. Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2-CCR2 axis. J. Immunol. 178: 5828-5838.